LifeStance Health Group Inc

LifeStance Health Group Inc(LFST)股票分析

$11.740

-0.598 (-5.09%)收盘时

Loading chart…
最高
12.490
开盘
12.450
成交量加权均价
11.97
成交量
2.82M
市值
1.87B
最低
11.680
成交额
33.81M
企业价值/息税折旧摊销前利润(TTM)
23.82

LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.

AI 分析 of LifeStance Health Group Inc (LFST)

买入

LifeStance Health Group Inc is a good buy right now due to its current price of $11.74 being significantly below analyst price targets, which range up to $19. Additionally, the company's strong revenue growth is evident with a year-to-date change of +68.68% and a one-year change of +127.52%. The main risk is the recent insider selling, with the CTO selling 42,067 shares, representing 17% of his holdings, which may raise concerns about insider confidence.

估值指标

LifeStance Health Group Inc(LFST)当前预期市盈率为 52.63,5 年平均预期市盈率为 8.55。

预期市盈率

合理
5 年均值 P/E
8.55
当前P/E
52.63
高估
104.39
低估
-87.30

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
35.18
当前EV/EBITDA
23.82
高估
50.66
低估
19.70

预期市销率

合理
5 年均值 P/S
2.29
当前P/S
2.40
高估
3.14
低估
1.44

Alphio AI 对 LFST 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%LFST

$8.88

情景价格

基

基准

基准 · 50%LFST

$8.02

情景价格

悲

悲观

悲观 · 25%LFST

$6.83

情景价格

持有 LFST 的大户

I

Integral Health Asset Management, LLC

+ 持有LFST

-8.91%

3个月收益率

T

TPG Capital, L.P.

+ 持有LFST

-9.38%

3个月收益率

事件时间线

2026-09-09 (ET)

09:00:00

Barclays Acts as Sole Book Running Manager for Offering

07:30:00

LifeStance Health Group to Offer 22.25M Shares of Common Stock

2026-08-10 (ET)

12:30:00

LifeStance Stock Rises 13.2% to $12.27

2026-08-06 (ET)

07:01:00

2026 Consensus Adjusted EBITDA Forecast $215M-$235M

07:01:00

Sees Q3 Adjusted EBITDA of $49M-$59M

资讯

LFST 常见问题 —— 由 Alphio AI 解答

LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

LifeStance Health Group Inc is a good buy right now due to its current price of $11.74 being significantly below analyst price targets, which range up to $19. Additionally, the company's strong revenue growth is evident with a year-to-date change of +68.68% and a one-year change of +127.52%. The main risk is the recent insider selling, with the CTO selling 42,067 shares, representing 17% of his holdings, which may raise concerns about insider confidence.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易